|
Previous: INSURED MUNICIPALS INCOME TR & IN QU TAX EX TR MUL SER 123, 24F-2NT, 2000-07-31 |
Next: CELL GENESYS INC, S-8, EX-4.1, 2000-07-31 |
As filed with the Securities and Exchange Commission on July 31, 2000
Registration No. _________
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
CELL GENESYS, INC. (Exact Name of Registrant as Specified in its Charter)
|
|
|
|
342 Lakeside Drive
Foster City, California 94404
(650) 425-4400
(Address, Including Zip Code, and Telephone Number, Including Area Code
of Registrar's Principal Executive Offices)
1998 Incentive Stock Plan (Full Title of the Plans)
Employee Stock Purchase Plan (Full Title of the Plans)
Matthew J. Pfeffer
Chief Financial Officer
CELL GENESYS, INC.
342 Lakeside Drive
Foster City, California 94404
(650) 425-4400
(Name, Address, Including Zip Code, and Telephone Number,
Including Area Code, of Agent for Service)
Copies to:
BARRY E. TAYLOR, ESQ.
Tracy Donsky, ESQ.
Wilson Sonsini Goodrich & Rosati
Professional Corporation
650 PAGE MILL ROAD
PALO ALTO, CA 94304-1050
(650) 493-9300
Approximate date of commencement of proposed sale to the public:
As soon as practicable after the effective date of this Registration Statement.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following.___
CALCULATION OF REGISTRATION FEE
Title of Each Class of Securities to be Registered
Amount to be Registered
Proposed Maximum Offering Price Per Share(1)
Proposed Maximum Aggregate Offering Price(1)
Amount of Registration Fee
Common Stock, $.001 par value
-- 1998 Incentive Stock Plan........
1,500,000 shares
$23.28(1)
$34,920,000.00(1)
$9,218.88
Common Stock, $.001 par value
-- Employee Stock Purchase Plan...
150,000 shares
$23.28(2)
$2,968,200.00(2)
$783.60
Total.............................
1,650,000 shares
$23.28
$37,888,200.00
$10,002.48
(1) Estimated in accordance with Rules 457(h) and 457(c) under the Securities
Act solely for the purpose of calculating the registration fee. In accordance
with rule 457 (h), the computation is based on the weighted average exercise
price of the options covered under the 1998 Incentive Stock Plan and the
Employee Stock Purchase Plan.
CELL GENESYS, INC. Item 3. Incorporation of Document by Reference. There are hereby incorporated by reference in this Registration
Statement the following documents and information previously filed with the
Securities and Exchange Commission (the "COMMISSION"):
(a) The Company's Annual Report on Form 10-K for the fiscal year ended
December 31, 1999 filed pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended (the "EXCHANGE ACT").
(b) The Company's Quarterly Report on Form 10-Q for the quarter ended
March 31, 2000 filed pursuant to Section 13(a) or 15(d) of the Exchange Act including
any amendment to such From 10-Q.
(c) The description of the Registrant's Common Stock and associated
preferred share purchase rights, contained in the Registrant's Registration
Statement on Form 8-A filed with the Commission on March 24, 1992 and August 8,
1995, registering such shares and associated rights pursuant to Section 12 of
the Exchange Act, including any amendment or report updating such descriptions.
All documents filed by the Company pursuant to Sections 13(a), 13(c), 14
and 15(d) of the Exchange Act subsequent to the filing of this Registration
Statement, and prior to the filing of a post-effective amendment that indicates
that all securities offered have been sold or that deregisters all securities
then remaining unsold, shall be deemed to be incorporated by reference in the
Registration Statement and to be part hereof from the date of filing such
documents.
Item 4. Description of Securities. Not applicable.
Item 5. Interests of Named Experts and Counsel. Not applicable.
Item 6. Indemnification of Directors and Officers. Section 145 of the Delaware General Corporation Law authorizes a court
to award or a corporation's Board of Directors to grant indemnification to
directors and officers in terms sufficiently broad to permit such
indemnification under certain circumstances for liabilities (including
reimbursement for expenses incurred) arising under the Securities Act of 1933
(the "SECURITIES ACT"), as amended. The Company has included in its Certificate
of Incorporation a provision that to the fullest extent permitted by Delaware
law, the Company's directors will not be liable for monetary damages for breach
of the directors' fiduciary duty of care to the Company and its stockholders. In
addition, the Company's Bylaws provide that the Company is required to indemnify
its officers and directors to the fullest extent permitted by Delaware law,
including those circumstances in which indemnification would otherwise be
discretionary, and that the Company is required to advance expenses to its
officers and directors as incurred. Further, the Company intends to enter into
indemnification agreements with its officers and directors, providing such
individuals indemnification to the maximum extent permitted by the Delaware
General Corporation Law.
Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the
Company pursuant to the Delaware General Corporation Law, the foregoing Bylaw
provision or any Indemnification Agreement, the Company has been informed that
in the opinion of the Securities and Exchange Commission such indemnification is
against public policy as expressed in the Securities Act and is therefore
unenforceable.
Item 7. Exemption from Registration Claimed. Not applicable.
Item 8. Exhibits.
Item 9. Undertakings. (a) The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being
made, a post-effective amendment to this Registration Statement to include any
material information with respect to the plan of distribution not previously
disclosed in the Registration Statement or any material change to such
information in the Registration Statement.
(2) That, for the purpose of determining liability under the
Securities Act, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
(3) To remove from registration by means of a post-effective
amendment any of the securities being registered that remain unsold at the
termination of the offering.
(b) The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act, each filling of the
Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the
Exchange Act (and, where applicable, each filing of an employee benefit plan's
annual report pursuant to Section 15(d) of the Exchange Act) that is
incorporated by reference in the Registration Statement shall be deemed to be a
new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be an initial bona
fide offering thereof.
(c) Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and controlling persons
of the Registrant pursuant to the Delaware General Corporation Law, the
Certificate of Incorporation of the Registrant, the Bylaws of the Registrant,
Indemnification Agreements entered into between the Registrant and its officers
and directors, or otherwise, the Registrant has been advised that in the opinion
of the Securities and Exchange Commission such indemnification is against public
policy as expressed in the Securities Act and is, therefore, unenforceable. In
the event that a claim for indemnification against such liabilities (other than
the payment by the Registrant of expenses incurred or paid by a director,
officer or controlling person of the Registrant in the successful defense of any
action, suit or proceeding) is asserted by such director, officer or controlling
person in connection with the securities being registered, the Registrant will,
unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the
Securities Act and will be governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the
Securities Act of 1933, the Registrant certifies that it has
reasonable grounds to believe that it meets all of the requirements
for filing on Form S-8 and has duly caused this Registration Statement
to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Foster City, State of California, on this
31st day of July, 2000.
REGISTRATION STATEMENT ON FORM S-8
PART II
INFORMATION REQUIRED IN REGISTRATION STATEMENT
1998 Incentive Stock Plan.
Employee Stock Purchase Plan.
Opinion of Wilson Sonsini Goodrich & Rosati,
P.C. as to legality of securities being
registered.
Consent of Wilson Sonsini Goodrich & Rosati,
P.C. (contained in Exhibit 5.1).
Consent of Ernst & Young LLP, Independent
Auditors.
Power of Attorney (see page II-4).
CELL GENESYS, INC.
CELL GENESYS, INC.
By:
/S/ MATTHEW J. PFEFFER
Matthew J. Pfeffer
Chief Financial Officer
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, each person whose signature appears below constitutes and appoints, Matthew J. Pfeffer, or his attorney-in-fact, for him in any and all capacitie sign any and all amendments to this Registration Statement on Form S-8, file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifyin confirming all that said attorney-in-fact, or his substitute may do or be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed bel the following persons in the capacities and on the dates indicated.
Signature |
Title |
Date |
/s/ STEPHEN A. SHERWIN, M.D. |
Chairman of the Board, President and Chief Executive Officer (Principal Executive Officer) |
July 31, 2000 |
/s/ MATTHEW J. PFEFFER |
Chief Financial Officer (Principal Financial and Accounting Officer) |
July 31, 2000 |
/s/ DAVID W. CARTER |
Director |
July 31, 2000 |
/s/ JAMES M. GOWER |
Director |
July 31, 2000 |
/s/ JOHN T. POTTS, JR., M.D. |
Director |
July 31, 2000 |
/s/ EUGENE L. STEP |
Director |
July 31, 2000 |
/s/ INDER M. VERMA, PH.D. |
Director |
July 31, 2000 |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
EXHIBITS
Registration Statement on Form S-8
CELL GENESYS, INC.
INDEX TO EXHIBITS
|
|
|
1998 Incentive Stock Plan. |
|
Employee Stock Purchase Plan |
|
Opinion of Wilson Sonsini Goodrich & Rosati, P.C. as to legality of securities being registered. |
|
Consent of Wilson Sonsini Goodrich & Rosati, P.C. (contained in Exhibit 5.1). |
|
Consent of Ernst & Young LLP, Independent Auditors. |
|
Power of Attorney (see page II-4). |
|